Medikabazaar is raising INR 433 Cr from CDC Group, existing investors
Image Credit: inc42
Mumbai-based B2B healthtech marketplace Medikabazaar is raising INR 433 Cr from a clutch of investors. UK-based CDC Group, Rebright Ventures are participating in this round of funding. According to the regulatory filings accessed by Inc42, Medikabazaar is allotting 6,38,357 Series C Compulsory Convertible Preference Shares at a premium of INR 6787.22 to ten investors.